Literature DB >> 14652741

Efficacy of an experimental fasciolicide against immature and mature Fasciola hepatica in artificially infected calves.

Y Vera Montenegro1, F Ibarra Velarde, E Liébano Hernández, H Quiroz Romero, R Castillo Bocanegra, A Hernández Campos, P Ochoa Galván.   

Abstract

The efficacy of 5-chloro-2-methylthio-6-(1-naphthyloxy)- 1H-benzimidazole, called "alpha", was tested against Fasciola hepatica. Fluke-free calves ( n=32) were divided into 8 groups and infected with 150 metacercariae per animal. All animals subsequently received a second infection with another 150 metacercariae, given at different time intervals aimed to produce flukes of differing ages within the experimental animals. When the flukes reached the required age in the animals, four groups were treated with a single oral dose of 12 mg/kg of compound alpha and the remaining ones served as non-treated controls. Two weeks after treatment the animals of all groups were sacrificed and the livers were removed to determine the numbers of parasites present in the treated and untreated controls. In the treated groups the fluke reduction for the 3 day/2 week group was 100%, for the 3 week/4 week group it was 96.4%, for the 6 week/8 week group it was 99.2% and for the 10 week/12 week group it was 100%.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14652741     DOI: 10.1007/s00436-003-1007-2

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  13 in total

1.  Triclabendazole-resistant Fasciola hepatica in southwest Wales.

Authors:  I Thomas; G C Coles; K Duffus
Journal:  Vet Rec       Date:  2000-02-12       Impact factor: 2.695

2.  Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole.

Authors:  Alicia Hernández-Campos; Froylán Ibarra-Velarde; Yolanda Vera-Montenegro; Norma Rivera-Fernández; Rafael Castillo
Journal:  Chem Pharm Bull (Tokyo)       Date:  2002-05       Impact factor: 1.645

3.  An experimental study on triclabendazole resistance of Fasciola hepatica in sheep.

Authors:  C P Gaasenbeek; L Moll; J B Cornelissen; P Vellema; F H Borgsteede
Journal:  Vet Parasitol       Date:  2001-02       Impact factor: 2.738

4.  Extension of the prepatent period of Fasciola hepatica in infected animals following treatment with triclabendazole.

Authors:  G Büscher; F L Bowen; M B Strong; J R Allison; R J Richards
Journal:  Vet Rec       Date:  1987-05-09       Impact factor: 2.695

5.  Efficacy of a fenbendazole-triclabendazole combination against Fasciola hepatica and gastrointestinal nematodes in sheep.

Authors:  W J Foreyt
Journal:  Vet Parasitol       Date:  1988-01       Impact factor: 2.738

6.  Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep.

Authors:  K Turner; J Armour; R J Richards
Journal:  Vet Rec       Date:  1984-01-14       Impact factor: 2.695

7.  Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands.

Authors:  L Moll; C P Gaasenbeek; P Vellema; F H Borgsteede
Journal:  Vet Parasitol       Date:  2000-07-24       Impact factor: 2.738

8.  Field trial on the efficacy of an experimental fasciolicide compared with some commercial compounds in naturally infected cattle.

Authors:  Y Vera Montenegro; F Ibarra Velarde; H Quiroz Romero; A Hernández Campos; R Castillo
Journal:  Parasitol Res       Date:  2003-07-03       Impact factor: 2.289

9.  Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole.

Authors:  J C Boray; P D Crowfoot; M B Strong; J R Allison; M Schellenbaum; M Von Orelli; G Sarasin
Journal:  Vet Rec       Date:  1983-10-01       Impact factor: 2.695

10.  Comparison of three ELISA tests for seroepidemiology of bovine fascioliosis.

Authors:  F Ibarra; N Montenegro; Y Vera; C Boulard; H Quiroz; J Flores; P Ochoa
Journal:  Vet Parasitol       Date:  1998-06-30       Impact factor: 2.738

View more
  6 in total

1.  Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha.

Authors:  Maeve McConville; Robert E B Hanna; Gerard P Brennan; Maurice McCoy; Hillary W J Edgar; Shirley McConnell; Rafael Castillo; Alicia Hernández-Campos; Ian Fairweather
Journal:  Parasitol Res       Date:  2009-11-18       Impact factor: 2.289

2.  Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.

Authors:  M McConville; G P Brennan; M McCoy; R Castillo; A Hernandez-Campos; F Ibarra; I Fairweather
Journal:  Parasitol Res       Date:  2006-10-03       Impact factor: 2.289

Review 3.  Current status of food-borne trematode infections.

Authors:  R Toledo; J G Esteban; B Fried
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-08       Impact factor: 3.267

4.  Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax).

Authors:  B McKinstry; L Halferty; G P Brennan; I Fairweather
Journal:  Parasitol Res       Date:  2008-11-18       Impact factor: 2.289

5.  Paramphistomicidal efficacy of an experimental compound in sheep.

Authors:  P M Reyes; V F Ibarra; M Y Vera; A G Cantó; A Hernández; C A Hernández; R Castillo; M A Villa
Journal:  Parasitol Res       Date:  2008-01-10       Impact factor: 2.289

6.  Tegumental surface changes in adult Fasciola hepatica following treatment in vitro and in vivo with an experimental fasciolicide.

Authors:  Norma Rivera; Froylán Ibarra; Armando Zepeda; Teresa Fortoul; Alicia Hernández; Rafael Castillo; Germinal Cantó
Journal:  Parasitol Res       Date:  2004-05-25       Impact factor: 2.289

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.